Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Huizing

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Pharmacological Research|October 23, 1998
Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancerV R Panday, M T Huizing, L J van Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreasR L Poorter, P J Bakker, M T Huizing, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionH Rosing, V Lustig, L J van Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2007
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up dataP M Specenier, D Van den Weyngaert, C Van Laer, et al.
Cancer Investigation|January 1, 1995
Taxanes: a new class of antitumor agentsM T Huizing, V H Misser, R C Pieters, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 1, 1995
Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcomaK M Hebeda, M T Huizing, P A Brouwer, et al.
British Journal of Clinical Pharmacology|October 16, 2007
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic studyM Joerger, A D R Huitema, M T Huizing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patientsM T Huizing, A C Keung, H Rosing, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
Clinical Drug Investigation|March 29, 2008
Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimensV R Nannan Panday, L J van Warmerdam, M T Huizing, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Pharmacological Research|October 23, 1998
Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancerV R Panday, M T Huizing, L J van Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreasR L Poorter, P J Bakker, M T Huizing, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionH Rosing, V Lustig, L J van Warmerdam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2007
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up dataP M Specenier, D Van den Weyngaert, C Van Laer, et al.
Cancer Investigation|January 1, 1995
Taxanes: a new class of antitumor agentsM T Huizing, V H Misser, R C Pieters, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 1, 1995
Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcomaK M Hebeda, M T Huizing, P A Brouwer, et al.
British Journal of Clinical Pharmacology|October 16, 2007
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic studyM Joerger, A D R Huitema, M T Huizing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patientsM T Huizing, A C Keung, H Rosing, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
Clinical Drug Investigation|March 29, 2008
Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimensV R Nannan Panday, L J van Warmerdam, M T Huizing, et al.
Pageof 4